|
26 Oct 2018 |
Social |
RT @LCalabreseDO: Pegloticase is clearly our most important agent in Pts with high uric Acid burdens - it’s Achilles heal is immunogenicity… |
|
|
26 Oct 2018 |
News |
Treat-to-Target Strategy Cuts Mortality in Gout Patients |
|
|
24 Oct 2018 |
Social |
RT @samwhittle: #ACR18 poster 1265:
Gout management in primary care can be improved with a thoughtful structured approach. Quantity and qua… |
|
|
23 Oct 2018 |
Social |
Filming now: our gout panel with these terrific people. We'll post it up tonight on https://t.co/X7Lh9aCbYf. #gout #ACR18 https://t.co/45xhhGs31t |
|
|
23 Oct 2018 |
Social |
RT @CCalabreseDO: prevalence of gout in the hip may be underestimated, as shown in abstract #2240 by use of ultrasound @RheumNow #ACR18 |
|
|
23 Oct 2018 |
Social |
RT @CCalabreseDO: allopurinol prescribing habits differ between rheumatologists and nephrologists. check out abstract #2228 @RheumNow #ACR18 |
|
|
23 Oct 2018 |
Social |
RT @DrPetryna: Abst L01 Risk of CV events in gout pts on XOI higher in pts with preexisting CVD: 16 events w/prior CV (23.2%), vs 6 w/no pr… |
|
|
23 Oct 2018 |
ACR Video |
Dr. Naomi Schlesinger: Gout Trials |
|
|
23 Oct 2018 |
ACR Video |
Dr. Cassie Calabrese: Gout |
|
|
22 Oct 2018 |
News |
TRIPLE Trial Results |
|
|
22 Oct 2018 |
ACR Video |
Dr. Sam Whittle: Five Factors in Gout |
|
|
22 Oct 2018 |
News |
Gout and the Social Determinants of Health |
|
|
21 Oct 2018 |
ACR Video |
Dr. Bill Shergy: Abstract on Gout - Does the Name Matter? |
|
|
19 Oct 2018 |
News |
Nurse Led Gout Management Highly Effective |
|
|
18 Oct 2018 |
News |
It's the Genes, Not the Diet that Raises Urate |
|
|
10 Oct 2018 |
Social |
CONTACT (Colchicine or Naproxen TX for Acute Gout) presented at the British Society of Rheum Mtg - 399 OL study finds equivalent responses betw Nap & Col, but trends favoring naproxen for lower early pain scores, side effects, less rescue pain meds https://t.co/MPgRNZo42b |
|
|
09 Oct 2018 |
News |
Allopurinol Shown to be Renal Protective |
|
|
28 Sep 2018 |
Social |
Horizon announces a new trial to evaluate the efficacy of MTX in prolonging efficacy and preventing anti-PEG antibodies in refractory gout patients treated with Pegloticase IV https://t.co/x47QSzwdmO |
|
|
18 Sep 2018 |
News |
Quarterly Canakinumab Reduces Gout Risk Without Affecting Uric Acid |
|
|
16 Sep 2018 |
Social |
10 yr study - 581 gout vs 598 OA pts shows gout with a lower risk of colorectal cancer (0.8% vs 3.7%). https://t.co/xPbj1iEGDs Other studies have shown increased overall Cancer risk in gout https://t.co/RDaDhm5V31 |
|
